Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of novel ABCB1 inhibitors that can help overcome ABCB1-mediated chemotherapy resistance

Dec. 29, 2021

WuXi Biologics and ImmuneOncia to jointly develop PD-L1/CD47 bispecific antibody

Dec. 28, 2021

Monoclonal antibodies can't keep Omicron variant in check

Dec. 28, 2021

Icaritin derivatives as potential DEPTOR inhibitors against multiple myeloma

Dec. 28, 2021

Searching for novel tricyclic M4 PAM scaffolds with improved pharmacological properties

Dec. 28, 2021

TMTP1 peptide dimer probe shows promise for tumor imaging and imaging-guided photothermal therapy

Dec. 28, 2021

Blocking phosphoglycerate dehydrogenase can reduce lymphoma progression

Dec. 28, 2021

MPI-8 selectively inhibits both SARS-CoV-2 MPro and the host cathepsin L

Dec. 28, 2021

Novel anti-CD19 CAR binds to a membrane-proximal domain of CD19 for treatment of B-cell malignancies

Dec. 28, 2021

BeiGene presents new IAP protein inhibitors

Dec. 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...